View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

GRI Bio Expands Intellectual Property Protection for Proprietary Natur...

GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation Continued advancement of an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, April 16, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T...

 PRESS RELEASE

Auri Inc. Announces New Business Development

Auri Inc. Announces New Business Development Auri Inc. Spins Off Several Wholly Owned Subsidiaries DALLAS, TX, April 16, 2024 (GLOBE NEWSWIRE) -- via -- Auri Inc. (OTCPK: AURI) (the Company) is a holding company with several wholly owned subsidiaries and companies in its portfolio. Today, the company is pleased to announce the modification to its business plan. The company and its consultants entered into several negotiations focused on spinning off several wholly owned subsidiaries. “The incredible response that our Knockout Line is receiving, prompted the management to fi...

 PRESS RELEASE

Mama’s Creations to Host Fourth Quarter and Fiscal Year 2024 Earnings ...

Mama’s Creations to Host Fourth Quarter and Fiscal Year 2024 Earnings Call on April 24 at 4:30 p.m. Eastern Time EAST RUTHERFORD, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, will release financial results for the fiscal fourth quarter and year ended January 31, 2024 after market close on April 24, 2024. Management will host an investor conference call at 4:30 p.m. Eastern time on Wednesday, April 24, 2024 to discuss the Company’s fourth quarter and fiscal year 2024 financial results, provide a corpor...

 PRESS RELEASE

Alliance Entertainment to Attend Music Biz 2024 in Nashville

Alliance Entertainment to Attend Music Biz 2024 in Nashville Company to Highlight Continued Success of Physical Media with Attendees K-Pop Sales Up 56.2% YoY through March 2024 to $49.8 Million PLANTATION, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: ), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, will attend the conference being held on May 13-16, 2024 at the JW Marriott Nashville in Nashville, Tennessee. The Music Business Association (Music Biz) brings t...

 PRESS RELEASE

Rigetti and Oxford Instruments Announce Successful Completion of Innov...

Rigetti and Oxford Instruments Announce Successful Completion of Innovate UK Project to Launch One of the First UK-Based Quantum Computers LONDON and OXFORD, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- Rigetti UK Limited, a wholly owned subsidiary of Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, and Oxford Instruments NanoScience, a leading provider of cryogenic systems, announce that their three-year project to build and operate one of the first quantum computers in the UK has been successfully completed. ...

 PRESS RELEASE

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Re...

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C. Telomir-1 elongates telomere caps on human normal embryonic fibroblast cells by stimulating the enzyme telomerase that protects the DNA and genetic material in chromosomes to combat aging Demonstrated a 40% increase in telomerase activity and lengthened telomeres in vitro in human cells Provided pre-clinical endpoints to determine “anti-aging” and “age-reversal” effects in dogs Outlined timeline for initiating human investigational new drug (IND) tr...

 PRESS RELEASE

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TE...

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic Neuropathy Rutherford, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced that it is expanding its glucose monitoring technology to include me...

 PRESS RELEASE

Nano Dimension Refreshes Corporate Governance by Appointing Major Gene...

Nano Dimension Refreshes Corporate Governance by Appointing Major General (Ret.) Eitan Ben-Eliahu to the Company’s Board of Directors Experienced Private Sector and National Service Leader Brings over 20 Years of Business Leadership Along With over 35 Year Distinguished Military Career Culminating by serving as The Commander in Chief of The Israeli Air Force Waltham, Mass, April 16, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimen...

 PRESS RELEASE

Horizon Aircraft Provides Corporate Update

Horizon Aircraft Provides Corporate Update ~ Substantive Progress in the Transition to Forward Flight Test Program of the Company’s Large-Scale Prototype eVTOL Aircraft ~ ~ Continuing Detailed Design of the Full-Scale Cavorite X7 Hybrid eVTOL Aircraft, on Track for Completion and Testing in 2026 ~ ~ Successful Completion of the Business Combination in January 2024 that Provided Proceeds to Continue Hybrid eVTOL Development ~ TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- New Horizon Aircraft Ltd. (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon” or the “Company”),...

 PRESS RELEASE

Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed...

Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path Disruptive Biotech Firm Appoints Public Markets Veteran Nelson Grist as its Chief Executive Officer and Future Member of its Board of Directors ARGYLE, TX, April 16, 2024 (GLOBE NEWSWIRE) -- via -- Black Bird Biotech, Inc. (OTC PINK:BBBT), a biotech, health, and wellness firm focused on disruptive technologies and innovations, today announced that it has appointed public markets veteran Nelson Grist as its Chief Executive Officer (CEO) and future Member of its Board of Directors. With over 15 years of exper...

 PRESS RELEASE

Lincoln Tech Awards Scholarships to Two Chicago-area Students

Lincoln Tech Awards Scholarships to Two Chicago-area Students Parsippany, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has awarded a pair of scholarships to Automotive Service & Technology students training at the campus in Melrose Park, IL, a suburb of Chicago. The campus has been one of Lincoln Tech’s longest-running schools, with a history of strong placement rates for graduates and close partnerships with area employers. Martiez Caffey and Dalia Alvarez will...

 PRESS RELEASE

SP Plus Corporation Launches its Bags® Branded Technology at the New B...

SP Plus Corporation Launches its Bags® Branded Technology at the New Brightline Orlando Station Enhancing the customer experience with unique technology solutions CHICAGO, April 16, 2024 (GLOBE NEWSWIRE) -- SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, announced a partnership with its subsidiary Bags® and Brightline high-speed rail service. Bags provides luggage handling services along with technology to print lug...

 PRESS RELEASE

CVR Energy to Release First Quarter 2024 Earnings Results

CVR Energy to Release First Quarter 2024 Earnings Results SUGAR LAND, Texas, April 16, 2024 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE: CVI) plans to release its first quarter 2024 earnings results on Monday, April 29, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Tuesday, April 30, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy’s website at . For investors or analysts who want t...

 PRESS RELEASE

CVR Partners to Release First Quarter 2024 Earnings Results

CVR Partners to Release First Quarter 2024 Earnings Results SUGAR LAND, Texas, April 16, 2024 (GLOBE NEWSWIRE) -- CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its first quarter 2024 earnings results on Monday, April 29, after the close of trading on the New York Stock Exchange. The Partnership also will host a teleconference call on Tuesday, April 30, at 11 a.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed o...

 PRESS RELEASE

Ducommun Incorporated Rejects Unsolicited, Non-Binding Indication of I...

Ducommun Incorporated Rejects Unsolicited, Non-Binding Indication of Interest From Albion River Proposal undervalues Ducommun and does not fully reflect the Company’s proven, long-term growth initiatives. Ducommun’s Board and Management remain focused on successfully delivering our Vision 2027 Strategy. SANTA ANA, Calif., April 16, 2024 (GLOBE NEWSWIRE) --  Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”), a global supplier of innovative electronic systems and structural solutions for the aerospace and defense industry, today responded to an unsolicited, non-binding indica...

 PRESS RELEASE

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neu...

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver, CO. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer, stated, “We are excited that our abstracts focused on XEN1101, including interim data from the ongoing X-TOLE open-label extension...

 PRESS RELEASE

SOLOWIN HOLDINGS Selected as a Key Participating Dealer for Harvest Gl...

SOLOWIN HOLDINGS Selected as a Key Participating Dealer for Harvest Global’s First Spot Bitcoin and Ethereum ETF in Hong Kong HONG KONG, April 16, 2024 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a securities brokerage company that offers comprehensive financial services primarily to Chinese investors, today announced that Solomon JFZ (Asia) Holdings Limited, its operating subsidiary, has been selected as one of the three participating dealers for Harvest Global’s spot Bitcoin and Ethereum ETF in Hong Kong. Harvest Global was one of the just three ETF...

 PRESS RELEASE

LOBO EV Received Strong Interest in its Solar-Powered EVs at 135th Can...

LOBO EV Received Strong Interest in its Solar-Powered EVs at 135th Canton Fair WUXI, China, April 16, 2024 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric vehicle manufacturer and seller, today announced it received strong interest from potential customers at the 135th China Import and Export Fair (“Canton Fair”), with more than 100 potential buyers visiting LOBO’s booth on the first day of the event. The Canton Fair is taking place on Pazhou Island, Guangzhou, China from April 15 to April 19, 2024. The Company is in ...

 PRESS RELEASE

Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In E...

Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool Company continues advancing ongoing development of targeted therapies for ulcerative colitis (UC) Carlsbad, CA, April 16, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, announced today the successful completion of its analysis evaluating ex-vivo bioactiv...

 PRESS RELEASE

RYVYL Inc. Announces Cancellation of Proposed Underwritten Public Offe...

RYVYL Inc. Announces Cancellation of Proposed Underwritten Public Offering San Diego, CA, April 16, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, today announced the cancellation of the proposed underwritten public offering of shares of its common stock originally announced on April 15, 2024. The cancellation results from an assessment by Company's management that current market pricing is n...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch